Literature DB >> 17384504

Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up.

John Souglakos1.   

Abstract

The genetics underlying an inherited predisposition to cancer are rapidly being uncovered. This fact may ultimately lead to the routine use of molecular tools to diagnose these disorders, and establish interventions to prevent the development of cancer. Among the multiple cancer family syndromes, several are known to be associated with the development of colon cancer. These disorders may be diagnosed during evaluation of the index patient or during screening of family members who are at risk. Although the effectiveness of screening and surveillance strategies is unproven in controlled clinical trials for any of these syndromes, the high cancer risk warrants screening, and reasonable recommendations can be made. Several other genetic syndromes are associated with gastrointestinal polyposis. The risk of colon cancer in these diseases is uncertain, and may not be increased and they are not mentioned in this review. Examples include Cowden disease, intestinal ganglioneuromatosis, Ruvalcaba-Myhre-Smith syndrome, Devon family syndrome, and Cronkite-Canada syndrome. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17384504     DOI: 10.1159/000099166

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  6 in total

1.  DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.

Authors:  Paulina Kopa; Anna Macieja; Elzbieta Pastwa; Ireneusz Majsterek; Tomasz Poplawski
Journal:  Mol Biol Rep       Date:  2021-01-02       Impact factor: 2.316

2.  The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.

Authors:  Qian Zuo; Renyi Wu; Xi Xiao; Caizhi Yang; Yuqing Yang; Chao Wang; Lizhu Lin; Ah-Ng Kong
Journal:  J Cell Biochem       Date:  2018-08-20       Impact factor: 4.429

Review 3.  Emerging roles for lncRNA-NEAT1 in colorectal cancer.

Authors:  Shirin Azizidoost; Farhoodeh Ghaedrahmati; Omid Anbiyaee; Riyadh Ahmad Ali; Maryam Cheraghzadeh; Maryam Farzaneh
Journal:  Cancer Cell Int       Date:  2022-06-08       Impact factor: 6.429

4.  Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.

Authors:  Dao-Rong Wang; Dong Tang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 5.  Mapping genetic research in non-communicable disease publications in selected Arab countries: first step towards a guided research agenda.

Authors:  Zeina Jamaluddine; Abla Mehio Sibai; Shahd Othman; Soha Yazbek
Journal:  Health Res Policy Syst       Date:  2016-11-10

Review 6.  Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence?

Authors:  Martina Perše
Journal:  Biomed Res Int       Date:  2013-05-14       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.